# DABIGATRAN

NDC: 60687-974
Generic name: DABIGATRAN ETEXILATE
Labeler / Manufacturer: American Health Packaging
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20260625

FDA application: ANDA213879

## Active ingredients

- DABIGATRAN ETEXILATE MESYLATE: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60687-974"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60687-974
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f7ea7e2c-ca54-4ecc-9fc7-bd3571b0ebc2